Virus Inactivation in the 1990s ? and into the 21st Century: Part 5: Disinfection

Publication

Article

February 15, 2003

BioPharm International

BioPharm International-02-01-2003

Volume16

Issue 2

Virus Inactivation in the 1990s ? and into the 21st Century: Part 5: Disinfection

by Gail Sofer, BioReliance Both the process and the product strongly influence viral inactivation, and unknown or unspecified details ? such as variability in virus titers, measuring devices, calibrations, and protocols ? can all influence log reduction values. This article series covers what you need to know to fully understand the properties of the test article, the viruses inactivated, and the critical control parameters for selected inactivation methods.

To view a PDF of this article from the BioPharm International archives, click this link

Articles in this issue

Becoming a Partner of Choice and Evaluating Prospective Alliances

Using Amino Acid Analysis to Determine Absorptivity Constants: A Validation Case Study Using Bovine Serum Albumin

Guest Editorial: Maybe You Need a Corporate Marriage Counselor

Inside Washington: AIDS Prevention Campaign Spotlights Biotech

The Double Helix at 50: A Half Century of Innovation in the Words of Eight Distinguished Scientists

Survival Strategies: Keeping Tabs on Training

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!